集学的治療が奏効した上顎歯肉無色素性悪性黒色腫の1例

Immunostimulatory effects of immune checkpoint inhibitors and radiotherapy have attracted much attention in the treatment of malignant melanoma. We present a case in which multidisciplinary treatment including both of these produced a remarkable antitumor effect in an amelanotic malignant melanoma (...

Full description

Saved in:
Bibliographic Details
Published in日本口腔外科学会雑誌 Vol. 67; no. 11; pp. 655 - 660
Main Authors 西川, 雅也, 小原, 豪, 日比, 英晴, 山口, 聡, 市村, 典久, 山本, 憲幸
Format Journal Article
LanguageJapanese
Published 公益社団法人 日本口腔外科学会 20.11.2021
Subjects
Online AccessGet full text
ISSN0021-5163
2186-1579
DOI10.5794/jjoms.67.655

Cover

Abstract Immunostimulatory effects of immune checkpoint inhibitors and radiotherapy have attracted much attention in the treatment of malignant melanoma. We present a case in which multidisciplinary treatment including both of these produced a remarkable antitumor effect in an amelanotic malignant melanoma (AMM).A 67-year-old woman visited the nearby general hospital with the chief complaint of a mass in the gingiva of the left maxilla. The mass was resected; however, since it was diagnosed as spindle cell carcinoma, she was referred to our hospital for additional treatment. A partial resection of the left maxilla was performed under general anesthesia, and histopathological examination revealed AMM. Additional resections were performed for positive excisional margins; however, four months later metastasis was found in the left upper internal deep cervical lymph node. Although a left radical neck dissection was performed, ten months later recurrence was observed in the left side mandibular branch medial and the left first sternocostal joint. Twelve courses of Nivolumab and four courses of Ipilimumab were administered, then following radiotherapy (32 Gy) the tumor disappeared. Three years and one month have passed since the end of treatment, and there has been no recurrence or distant metastasis.
AbstractList Immunostimulatory effects of immune checkpoint inhibitors and radiotherapy have attracted much attention in the treatment of malignant melanoma. We present a case in which multidisciplinary treatment including both of these produced a remarkable antitumor effect in an amelanotic malignant melanoma (AMM).A 67-year-old woman visited the nearby general hospital with the chief complaint of a mass in the gingiva of the left maxilla. The mass was resected; however, since it was diagnosed as spindle cell carcinoma, she was referred to our hospital for additional treatment. A partial resection of the left maxilla was performed under general anesthesia, and histopathological examination revealed AMM. Additional resections were performed for positive excisional margins; however, four months later metastasis was found in the left upper internal deep cervical lymph node. Although a left radical neck dissection was performed, ten months later recurrence was observed in the left side mandibular branch medial and the left first sternocostal joint. Twelve courses of Nivolumab and four courses of Ipilimumab were administered, then following radiotherapy (32 Gy) the tumor disappeared. Three years and one month have passed since the end of treatment, and there has been no recurrence or distant metastasis.
Author 日比, 英晴
西川, 雅也
山本, 憲幸
小原, 豪
市村, 典久
山口, 聡
Author_xml – sequence: 1
  fullname: 西川, 雅也
  organization: 公立西知多総合病院歯科口腔外科
– sequence: 1
  fullname: 小原, 豪
  organization: 名古屋大学大学院医学系研究科頭頸部・感覚器外科学講座顎顔面外科学
– sequence: 1
  fullname: 日比, 英晴
  organization: 名古屋大学医学部附属病院歯科口腔外科
– sequence: 1
  fullname: 山口, 聡
  organization: 名古屋大学医学部附属病院歯科口腔外科
– sequence: 1
  fullname: 市村, 典久
  organization: 名古屋大学医学部附属病院歯科口腔外科
– sequence: 1
  fullname: 山本, 憲幸
  organization: 名古屋大学医学部附属病院歯科口腔外科
BookMark eNo9kEtLw0AAhBepYK29-TdS99Hsbm5K8QUFL3oOm81GG_qQpBdvplShVRS8iHrQHlRQqlA8KAX_TJqk-RfGB15mYD4YhpkHuWarqQBYRLCkM6O85Lqthl-irER1fQbkMeJUQxnJgTyEGGk6omQOFH2_ZkGoc2YwQvOgmt4cR8OH5Lobj8bJVScMTqP786j_EQaXYXA7ee-ng7N4-Drt9JLuYNobJW938eFj3HnKNB1fZMn06DkMXtDk82QBzDqi7qvinxfAztrqdmVDq26tb1ZWqpqLCaIaRVgSmY3AtqMod6DiCFpUcgnLtsLIgA63sRCCKWIoC3HGBaOGZRuQMOkwUgDLv72u3xa7ytz3ag3hHZjCa9dkXZk_V5iUmQh9a3bIP5J7wjNdQb4AQCJ2cA
ContentType Journal Article
Copyright 2021 社団法人 日本口腔外科学会
Copyright_xml – notice: 2021 社団法人 日本口腔外科学会
DOI 10.5794/jjoms.67.655
DatabaseTitleList
DeliveryMethod fulltext_linktorsrc
EISSN 2186-1579
EndPage 660
ExternalDocumentID article_jjoms_67_11_67_655_article_char_ja
GroupedDBID ALMA_UNASSIGNED_HOLDINGS
F5P
JSF
KQ8
RJT
ID FETCH-LOGICAL-j2316-612c3c0052dfe68f0e810b6c8c04de2190f8d2aaa7e39eb1878a769bd9037cf73
ISSN 0021-5163
IngestDate Wed Sep 03 06:30:51 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 11
Language Japanese
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-j2316-612c3c0052dfe68f0e810b6c8c04de2190f8d2aaa7e39eb1878a769bd9037cf73
OpenAccessLink https://www.jstage.jst.go.jp/article/jjoms/67/11/67_655/_article/-char/ja
PageCount 6
ParticipantIDs jstage_primary_article_jjoms_67_11_67_655_article_char_ja
PublicationCentury 2000
PublicationDate 2021/11/20
PublicationDateYYYYMMDD 2021-11-20
PublicationDate_xml – month: 11
  year: 2021
  text: 2021/11/20
  day: 20
PublicationDecade 2020
PublicationTitle 日本口腔外科学会雑誌
PublicationTitleAlternate 日口外誌
PublicationYear 2021
Publisher 公益社団法人 日本口腔外科学会
Publisher_xml – name: 公益社団法人 日本口腔外科学会
References 15) Postow MA, Callahan MK, et al : Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 366: 925-931, 2012.
9) Yarchoan M, Hopkins A, et al : Tumor mutational burden and response rate to PD-1 inhibition. N Engl J Med 377: 2500-2501, 2017.
10) Valachis A and Ullenhag GJ : Discrepancy in BRAF status among patients with metastatic malignant melanoma: a meta-analysis. Eur J Cancer 81: 106-115, 2017.
16) Barker CA, Postow MA, et al : Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma. Cancer Immunol Res 1: 92-98, 2013.
11) Wada H, Nemoto K, et al : A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan. Int J Radiation Oncology Biol Phys 59: 495-500, 2004.
1) Qin R, Olson A, et al : Safety and efficacy of radiation therapy in advanced melanoma patients treated with ipilimumab. Int J Radiat Oncol Biol Phys 96: 72-77, 2016.
4) Robert C, Long GV, et al : Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 372: 320-330, 2015.
6) Nishino M, Giobbie HA, et al : Immune-related tumor response dynamics in melanoma patients treated with pembrolizumab: identifying markers for clinical outcome and treatment decisions. Clin Cancer Res 23: 4671-4679, 2017.
2) 杉浦 剛:口腔領域の悪性黒色種.白砂兼光, 古郷幹彦 編著;口腔外科学.第4版, 医歯薬出版, 東京, 2020, 302-304 頁
8) Sakaizawa K, Ashida A, et al : Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients. J Dermatol Sci 80: 33-37, 2015.
13) Demaria S, Kawashima N, et al : Immune-mediated inhibition of metastases following treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clin Cancer Res 11: 728-734, 2005.
5) Chiou VL and Burotto M : Pseudoprogression and immune-related response in solid tumors. J Clin Oncol 33: 3541-3543, 2015.
7) Oxnard GR, Morris MJ, et al : When progressive disease does not mean treatment failure: reconsidering the criteria for progression. J Natl Cancer Inst 104: 1534-1541, 2012.
14) Grimaldi AM, Simeone E, et al : Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy. Onco-Immunology 3: e28780, 2014.
3) Matsumoto T, Yokota K, et al : Postoperative DAV-IFN-β therapy does not improve survival rates of stage II and stage III melanoma patients significantly. J Eur Acad Dermatol Venereol 27: 1514-1520, 2013.
12) Abuodeh Y, Venkat P, et al : Systematic review of case reports on the abscopal effect. Curr Probl Cancer 40: 25-37, 2016.
References_xml – reference: 1) Qin R, Olson A, et al : Safety and efficacy of radiation therapy in advanced melanoma patients treated with ipilimumab. Int J Radiat Oncol Biol Phys 96: 72-77, 2016.
– reference: 3) Matsumoto T, Yokota K, et al : Postoperative DAV-IFN-β therapy does not improve survival rates of stage II and stage III melanoma patients significantly. J Eur Acad Dermatol Venereol 27: 1514-1520, 2013.
– reference: 12) Abuodeh Y, Venkat P, et al : Systematic review of case reports on the abscopal effect. Curr Probl Cancer 40: 25-37, 2016.
– reference: 11) Wada H, Nemoto K, et al : A multi-institutional retrospective analysis of external radiotherapy for mucosal melanoma of the head and neck in Northern Japan. Int J Radiation Oncology Biol Phys 59: 495-500, 2004.
– reference: 8) Sakaizawa K, Ashida A, et al : Clinical characteristics associated with BRAF, NRAS and KIT mutations in Japanese melanoma patients. J Dermatol Sci 80: 33-37, 2015.
– reference: 4) Robert C, Long GV, et al : Nivolumab in previously untreated melanoma without BRAF mutation. N Engl J Med 372: 320-330, 2015.
– reference: 7) Oxnard GR, Morris MJ, et al : When progressive disease does not mean treatment failure: reconsidering the criteria for progression. J Natl Cancer Inst 104: 1534-1541, 2012.
– reference: 9) Yarchoan M, Hopkins A, et al : Tumor mutational burden and response rate to PD-1 inhibition. N Engl J Med 377: 2500-2501, 2017.
– reference: 2) 杉浦 剛:口腔領域の悪性黒色種.白砂兼光, 古郷幹彦 編著;口腔外科学.第4版, 医歯薬出版, 東京, 2020, 302-304 頁.
– reference: 13) Demaria S, Kawashima N, et al : Immune-mediated inhibition of metastases following treatment with local radiation and CTLA-4 blockade in a mouse model of breast cancer. Clin Cancer Res 11: 728-734, 2005.
– reference: 16) Barker CA, Postow MA, et al : Concurrent radiotherapy and ipilimumab immunotherapy for patients with melanoma. Cancer Immunol Res 1: 92-98, 2013.
– reference: 15) Postow MA, Callahan MK, et al : Immunologic correlates of the abscopal effect in a patient with melanoma. N Engl J Med 366: 925-931, 2012.
– reference: 5) Chiou VL and Burotto M : Pseudoprogression and immune-related response in solid tumors. J Clin Oncol 33: 3541-3543, 2015.
– reference: 10) Valachis A and Ullenhag GJ : Discrepancy in BRAF status among patients with metastatic malignant melanoma: a meta-analysis. Eur J Cancer 81: 106-115, 2017.
– reference: 6) Nishino M, Giobbie HA, et al : Immune-related tumor response dynamics in melanoma patients treated with pembrolizumab: identifying markers for clinical outcome and treatment decisions. Clin Cancer Res 23: 4671-4679, 2017.
– reference: 14) Grimaldi AM, Simeone E, et al : Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy. Onco-Immunology 3: e28780, 2014.
SSID ssib005879736
ssib058493840
ssj0001742264
ssib000940266
Score 2.2861931
Snippet Immunostimulatory effects of immune checkpoint inhibitors and radiotherapy have attracted much attention in the treatment of malignant melanoma. We present a...
SourceID jstage
SourceType Publisher
StartPage 655
SubjectTerms 仮性増悪
免疫チェックポイント阻害薬
免疫賦活作用
放射線治療
無色素性悪性黒色種
Title 集学的治療が奏効した上顎歯肉無色素性悪性黒色腫の1例
URI https://www.jstage.jst.go.jp/article/jjoms/67/11/67_655/_article/-char/ja
Volume 67
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX 日本口腔外科学会雑誌, 2021/11/20, Vol.67(11), pp.655-660
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 2186-1579
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0001742264
  issn: 0021-5163
  databaseCode: KQ8
  dateStart: 19670101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LaxRBEB5CvHgRRcU3Ae2TTJxHTz-OPZsJwRcICeS2zPOwYCKaXDy5IQqJouBF1IPmoIISheBBCfhnNtlN_oVf98xsJuIhPi5DbVV1dXVVz1TV7HS3ZV3yMjzzs5TZCFWBTYsst2MZcztH6EvzBDPAbJJ04yabmqFXZ4PZkdGLja-WFheS8fT-b9eV_I1XgYNf9SrZP_DsUCgQgOFfXOFhXA_kYxJJIkMiGIkCoiaIAsCJVERQEjESeiQMDUYS4ZHIR9pIRMswB0RMakAoEsqKJHkNgERJKDQVXSi0irRA3QVIQksTUktGR6BqjNTdARMC42hm4RDFDeARpRoYqbWSXqMVAKgUVr2ryDXdR0SEzdxZi4CKUF0DLaLMSDAM5VciJDVjo0QaQ6Az6TZMA5ktbZ3SatLoDc3E8EWxQQQkNJYJ0XpCz8DayoGRAHhyjx9sTm3JSNvN8AsSYhhqj62hOAwINSs2EWpOTYYh6D6xrqHU46v5IdZtvqjxXL1i0XOGt5ZpEhjbcKO1MpYw5gQJGG0tzA2fyHJAmADq8v-ybTMIQrfAreJKbnD6ZDLbDcpzferAWJ6TUj8A3EaYY-XWylXGxMoTIX4NxpBGdTDuzN--N874-LDRvu3Nq5unbdjajKMk1Vcwt2uSXn_Y7qAIOuQhdOvzWa7datQQkjpeoyYJBJfcH_5Ggi39ekMj8-KVm8Xj5adfpSHKBTFa3ytNbZGUdlCi1Z93moxz-qh1pCoVx1Sp3zFrpBMft67vvn60vf5-8Gq5v7E5eLnU6z7Zfvdse_V7r_ui132z9W11d-1pf_3LztLKYHltZ2Vj8PVt_8GH_tJHXHc3nwOz8_BTr_vZ3frx-IQ1MxlNt6bs6kQUu4M6jNkoR1I_1X_lZEXOROHkwnUSlorUoVmO5MMpRObFccxzXyILE1zEnMkkk46v9x_zT1qjc_Nz-SlrjLKMBkBKWcSUsSRJi4R7niwEBAYpPW3JcvDtO-W2N-2De-rMP7Q9ax3eu3nOWaMLdxfz88j7F5ILxu8_AVU3zkw
linkProvider Colorado Alliance of Research Libraries
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=%E9%9B%86%E5%AD%A6%E7%9A%84%E6%B2%BB%E7%99%82%E3%81%8C%E5%A5%8F%E5%8A%B9%E3%81%97%E3%81%9F%E4%B8%8A%E9%A1%8E%E6%AD%AF%E8%82%89%E7%84%A1%E8%89%B2%E7%B4%A0%E6%80%A7%E6%82%AA%E6%80%A7%E9%BB%92%E8%89%B2%E8%85%AB%E3%81%AE1%E4%BE%8B&rft.jtitle=%E6%97%A5%E6%9C%AC%E5%8F%A3%E8%85%94%E5%A4%96%E7%A7%91%E5%AD%A6%E4%BC%9A%E9%9B%91%E8%AA%8C&rft.au=%E8%A5%BF%E5%B7%9D%2C+%E9%9B%85%E4%B9%9F&rft.au=%E5%B0%8F%E5%8E%9F%2C+%E8%B1%AA&rft.au=%E6%97%A5%E6%AF%94%2C+%E8%8B%B1%E6%99%B4&rft.au=%E5%B1%B1%E5%8F%A3%2C+%E8%81%A1&rft.date=2021-11-20&rft.pub=%E5%85%AC%E7%9B%8A%E7%A4%BE%E5%9B%A3%E6%B3%95%E4%BA%BA+%E6%97%A5%E6%9C%AC%E5%8F%A3%E8%85%94%E5%A4%96%E7%A7%91%E5%AD%A6%E4%BC%9A&rft.issn=0021-5163&rft.eissn=2186-1579&rft.volume=67&rft.issue=11&rft.spage=655&rft.epage=660&rft_id=info:doi/10.5794%2Fjjoms.67.655&rft.externalDocID=article_jjoms_67_11_67_655_article_char_ja
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-5163&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-5163&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-5163&client=summon